Project Updates and Milestones news (page 2)

• 

  18 December 2025

  Johnson & Johnson's TRUFILL n-BCA Approved by FDA for Chronic Subdural Hematoma Treatment

  FDA approves TRUFILL n-BCA for MMA embolization in chronic subdural hematoma, offering a minimally invasive alternative to surgery with proven safety and effectiveness.
• 

  18 December 2025

  Lilly's Orforglipron Maintains Weight Loss in Phase 3 Trial

  Orforglipron met primary and key secondary endpoints for weight maintenance at 52 weeks post-weight loss on Wegovy. FDA submission for obesity treatment is underway.
• 

  18 December 2025

  Novo Nordisk Seeks FDA Approval for CagriSema, a Weekly Obesity Treatment

  CagriSema, combining cagrilintide and semaglutide, shows 23% weight loss in trials. If approved, it offers a new obesity treatment option.
• 

  18 December 2025

  Novo Nordisk Seeks FDA Approval for CagriSema, a Weekly Obesity Treatment

  CagriSema, a weekly injectable combining GLP-1 and amylin analogues, shows promising weight loss results in trials and awaits FDA review for obesity management.
• 

  18 December 2025

  H₂CAST Component Transport Marks Milestone for STORAG and Gasunie

  A key H₂CAST component traveled from Rotterdam to Etzel, marking progress in hydrogen infrastructure, with commissioning set for early 2026 and testing to follow.
• 

  18 December 2025

  Aisti secures €20M EIB loan for sustainable acoustic tiles expansion

  EIB loan boosts production of bio-based acoustic tiles, supporting EU green goals and rural development, while enhancing R&D for improved properties and market expansion.

• 

  18 December 2025

  Takeda's Zasocitinib Phase 3 Trials Show Promise for Plaque Psoriasis Treatment

  Zasocitinib met all primary and secondary endpoints in Phase 3 trials, showing potential for clear skin in plaque psoriasis with a consistent safety profile.
• 

  18 December 2025

  Sumitomo's Five Estuaries Wind Farm Gains UK Development Consent

  The project secured UK government consent, aims for 1080MW capacity, and plans to start power generation post-2030, supporting up to 1 million UK homes.
• 

  17 December 2025

  Johnson & Johnson's RYBREVANT FASPRO™ Gains FDA Approval for Faster NSCLC Treatment

  FDA approves RYBREVANT FASPRO™ for EGFR-mutated NSCLC, offering faster, subcutaneous administration with fewer side effects compared to IV delivery.
• 

  17 December 2025

  WITTMANN Expands Production in China

  WITTMANN's Kunshan plant now produces injection molding machines locally, doubling capacity and enhancing efficiency. The site will also serve as a development hub for tailored solutions.
• 

  17 December 2025

  MOL: Danube Refinery Repairs Expected by Q3 2026

  A fire at the Danube Refinery was caused by equipment failure. Repairs are underway, with insurance claims in progress. Production loss is mitigated by increased feedstock processing and imports.
• 

  17 December 2025

  Eni and ILO Enhance Safety and Health in Republic of Congo

  The project aims to improve occupational safety and social protection for agri-business workers in the Republic of Congo, building on success in Kenya and Côte d’Ivoire.
• 

  17 December 2025

  Merck's KEYTRUDA and Padcev Enhance Survival in Cisplatin-Eligible MIBC Patients

  KEYTRUDA and Padcev improve survival and response rates in MIBC patients, showing promise as perioperative treatment with consistent safety profiles.
• 

  17 December 2025

  MOL Group and SOCAR Sign Onshore Exploration Agreement

  MOL and SOCAR partner for hydrocarbon exploration in Azerbaijan's Shamakhi-Gobustan region, with MOL as operator. Seismic survey set for 2026, followed by drilling.
• 

  17 December 2025

  Iberdrola Uses Seville-Made Solutions for German Offshore Wind Farm Protection

  Transition pieces at the Windanker wind farm are coated with a cork compound to endure marine conditions, with RTS evolving to offer marine protection solutions.
• 

  16 December 2025

  Avantium Updates on Government Funding Timeline

  Funding timeline delayed due to extended government procedures. Avantium remains confident in securing support after ongoing discussions.
• 

  16 December 2025

  UPM Ends Graphic Paper Production in Ettringen

  UPM will close its Ettringen mill by December 31, 2025, affecting 189 jobs. An after-care team and a transfer company will support impacted employees.
• 

  16 December 2025

  Shell Invests in Kaikias Waterflood Project in Gulf of America

  Shell's Kaikias waterflood project aims to boost oil recovery and extend Ursa platform's lifecycle in the Gulf of America, with first injection set for 2028.
• 

  16 December 2025

  Statkraft and Fortescue Update Power Deal for Norway Hydrogen Project

  The agreement now extends to 2029, covering a 10-year power supply, supporting ongoing studies and approvals for the Holmaneset project.
• 

  15 December 2025

  Janssen's TECVAYLI® and DARZALEX FASPRO® Join FDA's Priority Voucher Program

  TECVAYLI® and DARZALEX FASPRO® show significant survival benefits in multiple myeloma, gaining FDA Breakthrough Therapy Designation and Real-Time Oncology Review.
• 

  15 December 2025

  Lummus and Advanced Ionics Launch Green Hydrogen Pilot Plant

  A pilot plant for green hydrogen electrolyzer technology is underway in Pasadena, Texas, aiming to accelerate commercialization and validate real-world performance.
• 

  15 December 2025

  Borealis Settles Kallo PDH2 Dispute

  Borealis and IREM Group settle contract dispute, ending arbitration and allowing both parties to proceed.
• 

  15 December 2025

  thyssenkrupp Polysius Aids SMA Mineral in EAC Pilot Plant Pre-Engineering

  Developing a flash calcination plant in Norway, focusing on preheating and cooling systems, to enhance lime production efficiency and reduce emissions.
• 

  15 December 2025

  Technip Energies Wins Engineering Contract for Thailand's First CCS Project

  Technip Energies to engineer Thailand's first CCS project, enhancing Arthit field infrastructure to capture 1 million tonnes of CO2 annually, supporting national decarbonization goals.
• 

  12 December 2025

  Lilly's Inluriyo™ Shows Efficacy in ER+, HER2- Breast Cancer

  Inluriyo™ improves survival in ER+, HER2- breast cancer, both alone and with abemaciclib, extending time to chemotherapy and showing durable benefits across patient groups.
• 

  12 December 2025

  FDA Approves Johnson & Johnson's AKEEGA for BRCA2-Mutated Prostate Cancer

  FDA approves AKEEGA for BRCA2-mutated prostate cancer, reducing disease progression by 54% and delaying symptoms by 59% in clinical trials.
• 

  12 December 2025

  Merck's WINREVAIR™ Gains EU CHMP Support for Broader PAH Use

  EU CHMP backs expanded WINREVAIR™ use for PAH, covering WHO FC II-IV. Decision by European Commission expected Q1 2026.
• 

  11 December 2025

  Uniper's 50 MW Battery Storage Approved at Wilhelmshaven

  The facility will enhance grid stability and support renewable integration. A solar plant is also under construction, with commissioning set for July 2026.
• 

  11 December 2025

  Johnson Matthey Opens Hydrogen Engine Facility in Gothenburg

  The new facility tests hydrogen engines for decarbonizing heavy transport, supporting cleaner mobility and regulatory needs with a £2.5m investment.
• 

  11 December 2025

  EnviTec Biogas Secures Three New Gas Upgrading Contracts in Germany

  New gas upgrading projects in Bavaria, Bremen, and Saxony-Anhalt will enhance local networks with flexible, efficient EnviThan plants, addressing space constraints and future expansion needs.